Evidence map›Paper›PMID 37838572›Full record

ArticleResearch in social & administrative pharmacy : RSAP2024

Back to the basics: Guidance for formulating good research questions.

Jordan R Covvey, Chyna McClendon, Michael R Gionfriddo

Open access · greenAbstract read
In one paragraph

Article in Research in social & administrative pharmacy : RSAP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The importance of rigor in pharmacy research: Challenges and solutions.Research in social & administrative pharmacy : RSAP · 2025
    Article
  10. Article
  11. Review
  12. Back to the basics: Guidance for designing good literature searches.Research in social & administrative pharmacy : RSAP · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jordan R CovveyDuquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, USA.
Chyna McClendonDuquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, USA.
Michael R GionfriddoDuquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, USA. Electronic address: gionfriddom@duq.edu.
Duquesne University · US

Funding

Enhancing experimental rigor through education in evidence synthesisUE5NS128228 · NINDS · DUQUESNE UNIVERSITY · PI COVVEY, JORDAN RANDALL, GIONFRIDDO, MICHAEL ROSS · 2022 to 2024
$269k
NINDS NIH HHS UE5 NS128228
6 · The paper itself

Abstract

Good science is driven by rigorous questions. Much like the foundation of a house, a research question must be carefully constructed to prevent downstream problems in project execution. And yet, pharmacy researchers and scholars across all career stages may find themselves struggling when developing research questions. The purpose of this commentary is to provide useful guidance on composing and evaluating rigorous research questions. A variety of frameworks, such as PICO (Patient/population; Intervention; Comparison; Outcome), are available to researchers and can assist them in ensuring that their research question has covered all relevant components. Additionally, the FINER (Feasible; Interesting; Novel; Ethical; and Relevant) criteria can help researchers with evaluating their research questions for practical considerations. Finally, building awareness of common pitfalls when composing research questions can aid researchers to avoid issues that they may not otherwise discover until their manuscript undergoes peer review.

Indexed as

PharmacyHumansResearch DesignBiomedical researchPeer reviewPharmacy researchResearchResearch design

Identifiers

PMID37838572
PMCPMC11129835
OpenAlexW4387578446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.